神经肽与皮肤病(3)
[7] Eedy DJ.Neuropeptides in skin.Br J Dermatol，1993,128:597-605.
[8] Kahler CM ,Sitte BA,Reinisch N,et al.Stimulation of the chemotatic migration of human fibroblasts by substance.P.Eur J PhARMACOL,1993,249(3):281-6.
[9] Parenti A,Amerini S,LeddsF,et al.The tachkininNK1receptor mediates the migration promoting effect of aubstance P on human skin fibroblasts in culture. Naunyn Schmiedebergs Arch Pharmacol,1996,353(3):475-81.
, http://www.100md.com
[10] Pincelli C,et al.Neuropeptides in skin from patients with atopic dermatitis:an immunohistochemical study.Br J Dermaol,1990,122:745.
[11] ALAbadie MSK .et al.The immnnoreativity of neuropeptides and general neuronal marker PGP9.5 in atopic dermatitis.Br J Dermaol,1992:127:430.
[12] Anand P,et al.Neuropeptides in skin disease:incressed VIP in eczema and psoriasis but not axillary hyperhydrosis. Br J Dermatol ,1991,124:547.
, 百拇医药
[13] 刘伟，赵庆利.菜瑞康.神经肽在变应性皮炎及正常皮肤中的分布观察.空军总医院学报, 1994，10(1)：7-9.
[14] Ganneii A, Grotomoni G.Skin reactivity to neuropeptides in atopic dermatitis.Br J Dermatol,1989,121(6);681-688.
[15] Wallengren J,Substance P antagonist inhibits immediate and delayed type cutaneous hypersensitivity reaction.Br J Dermatol,1991,124:324.
[16] Ohshiroh,Suzuki K,Furuno T,et al.Atomic force microscopy to study direct neurte-mast cell (RBL) communication in vitro.Immunol Letters,2001,74:211-214.
, 百拇医药
[17] 齐宝全，陆洁，段昕所，等.银屑病 皮损处角质形成细胞中P物质的研究[J].临床皮肤科杂志,2004,33(7):415-416.
[18] Eedy DJ,Johnson CF,Shaw C,et al.Neuropeptides in psoriasis:an immunocytochemical and radioimmunoassay study.J Invest Dermatol ,1991,96:434-438.
[19] Al,Abadie MSK,Senior HJ,Bleehen SS,et al.Neurogenic changes in psoriasis.An immunohistochemical study.J Invest Dermatol,1992,98:535.
[20] Pincelli C,Fantini F,Romualdi P is diminished and vasoactive intestinal peptide is augmented in psoriatic lesions and these peptides exertdisparate effects on the proliferation of cultured human keratinocytes.J Invest Dermatol,1992,98:421-427.
, 百拇医药
[21] Al,Abadie MSK et al.Neurppeptide and neuronal marker studies in vitiligo Br J Dermatol,1994,131:160.
[22] 邓宝珍，邓宝丽.神经肽P物质在白殿风发病机制中的初探 中国皮肤性病学杂志,1997,11:145-146.
[23] 曾维惠,谭升顺,姚聪君,等.白癜风皮损中NPY、VIP 和SP的研究.中国皮肤性病学杂志,2002,16(1):12-13.
[24] Coebeler M et al.Arch Dermatol Res,1994;286:341.
[25] Crowe H,Parkhouse N,McGrouther D,et al.Neuropeptide-containing nerves in painful hypertrophic human scar tissue[J].Br J Dermatol,1994,130(4):444-452.
, http://www.100md.com
[26] 从 林，李世荣，许友奇.增生性瘢痕P物质含量的放免测定[J].中华整形烧伤外科杂志，1998，14(6)：401-403.
[27] 冯小剑.神经肽与皮肤病.北京军区医药，1999，11(6)：446-447.
[28] Eedy DJ,Johnston CF,Shaw C et al.Neuropeptions in psoriasis.J Invest Dermatol,1991,96:434.
[29] Leslie TA et al.Br J DERMATOL,1994,131:423.
[30] Bran SD,Tippins JR,Morris HR et al.Potent vasodilator activity of calcitonin gene-related peptide in human skin .J Invest Dermatol,1986,87(4):533-536.
[31] Gustafsson H, Nilsson H. Endothlium-independent potentiation by Neuropeptide y of vasoconstrictor response in isolated arteries form rat and rabbit.Acta Physiol Scand,1990,138:503., http://www.100md.com(周建华 高顺强 林元珠)
[8] Kahler CM ,Sitte BA,Reinisch N,et al.Stimulation of the chemotatic migration of human fibroblasts by substance.P.Eur J PhARMACOL,1993,249(3):281-6.
[9] Parenti A,Amerini S,LeddsF,et al.The tachkininNK1receptor mediates the migration promoting effect of aubstance P on human skin fibroblasts in culture. Naunyn Schmiedebergs Arch Pharmacol,1996,353(3):475-81.
, http://www.100md.com
[10] Pincelli C,et al.Neuropeptides in skin from patients with atopic dermatitis:an immunohistochemical study.Br J Dermaol,1990,122:745.
[11] ALAbadie MSK .et al.The immnnoreativity of neuropeptides and general neuronal marker PGP9.5 in atopic dermatitis.Br J Dermaol,1992:127:430.
[12] Anand P,et al.Neuropeptides in skin disease:incressed VIP in eczema and psoriasis but not axillary hyperhydrosis. Br J Dermatol ,1991,124:547.
, 百拇医药
[13] 刘伟，赵庆利.菜瑞康.神经肽在变应性皮炎及正常皮肤中的分布观察.空军总医院学报, 1994，10(1)：7-9.
[14] Ganneii A, Grotomoni G.Skin reactivity to neuropeptides in atopic dermatitis.Br J Dermatol,1989,121(6);681-688.
[15] Wallengren J,Substance P antagonist inhibits immediate and delayed type cutaneous hypersensitivity reaction.Br J Dermatol,1991,124:324.
[16] Ohshiroh,Suzuki K,Furuno T,et al.Atomic force microscopy to study direct neurte-mast cell (RBL) communication in vitro.Immunol Letters,2001,74:211-214.
, 百拇医药
[17] 齐宝全，陆洁，段昕所，等.银屑病 皮损处角质形成细胞中P物质的研究[J].临床皮肤科杂志,2004,33(7):415-416.
[18] Eedy DJ,Johnson CF,Shaw C,et al.Neuropeptides in psoriasis:an immunocytochemical and radioimmunoassay study.J Invest Dermatol ,1991,96:434-438.
[19] Al,Abadie MSK,Senior HJ,Bleehen SS,et al.Neurogenic changes in psoriasis.An immunohistochemical study.J Invest Dermatol,1992,98:535.
[20] Pincelli C,Fantini F,Romualdi P is diminished and vasoactive intestinal peptide is augmented in psoriatic lesions and these peptides exertdisparate effects on the proliferation of cultured human keratinocytes.J Invest Dermatol,1992,98:421-427.
, 百拇医药
[21] Al,Abadie MSK et al.Neurppeptide and neuronal marker studies in vitiligo Br J Dermatol,1994,131:160.
[22] 邓宝珍，邓宝丽.神经肽P物质在白殿风发病机制中的初探 中国皮肤性病学杂志,1997,11:145-146.
[23] 曾维惠,谭升顺,姚聪君,等.白癜风皮损中NPY、VIP 和SP的研究.中国皮肤性病学杂志,2002,16(1):12-13.
[24] Coebeler M et al.Arch Dermatol Res,1994;286:341.
[25] Crowe H,Parkhouse N,McGrouther D,et al.Neuropeptide-containing nerves in painful hypertrophic human scar tissue[J].Br J Dermatol,1994,130(4):444-452.
, http://www.100md.com
[26] 从 林，李世荣，许友奇.增生性瘢痕P物质含量的放免测定[J].中华整形烧伤外科杂志，1998，14(6)：401-403.
[27] 冯小剑.神经肽与皮肤病.北京军区医药，1999，11(6)：446-447.
[28] Eedy DJ,Johnston CF,Shaw C et al.Neuropeptions in psoriasis.J Invest Dermatol,1991,96:434.
[29] Leslie TA et al.Br J DERMATOL,1994,131:423.
[30] Bran SD,Tippins JR,Morris HR et al.Potent vasodilator activity of calcitonin gene-related peptide in human skin .J Invest Dermatol,1986,87(4):533-536.
[31] Gustafsson H, Nilsson H. Endothlium-independent potentiation by Neuropeptide y of vasoconstrictor response in isolated arteries form rat and rabbit.Acta Physiol Scand,1990,138:503., http://www.100md.com(周建华 高顺强 林元珠)